Tue, May 21, 2024

Jessica Fye Maintained (UTHR) at Buy with Increased Target to $300 on, May 21st, 2024

Jessica Fye of JP Morgan, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $280 to $300 on, May 21st, 2024.

Jessica has made no other calls on UTHR in the last 4 months.



There are 6 other peers that have a rating on UTHR. Out of the 6 peers that are also analyzing UTHR, 1 agrees with Jessica's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024


These are the ratings of the 5 analyists that currently disagree with Jessica


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 2nd, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $325 on, Thursday, March 7th, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024